MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10)

J. Vizcarra, A. Merola, D. Torres-Russotto, G. Stebbins, A. Wagle Shukla, A. Hassan, L. Marsili, J. Krauss, R. Elble, G. Deuschl, A. Espay (Atlanta, GA, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1280

Keywords: Orthostatic tremor (also see Tremors), Scales

Category: Rating Scales

Objective: To develop and validate a severity and disability self-administered scale for orthostatic tremor (OT).

Background: OT is characterized by a 13-18 Hz tremor in weight-bearing limbs during standing that attenuates on leaning against an object and disappears on sitting or walking. [1] Studies have relied on electromyography, total standing time, or a combination of patient and physician-rated questionnaires as surrogate measures of severity and disability in the absence of a validated clinical scale. [2]

Method: This multicenter scale development and validation trial followed a multi-step Delphi method for consensus. [3] Step one was the generation of the initial 42-item pool through literature review and expert opinion. Step two was first scale draft via patients’ focus groups. Step three was formal cognitive debriefing. Step four was psychometric testing for acceptability and distributional skewness of items, global scale reliability, construct validity, and convergent validity anchored on the examiner’s Clinical Global Impression Score (CGI) [figure1]. Steps two and three used a Framework method for qualitative data analysis, [4] while step four used Classical Test Theory. [5] A 4.5:1 subject-to-item ratio was used for sample size. [6]

Results: Eleven items ranked on a Likert scale from 0 (no disability/severity) to 5 (maximal disability/severity) were evaluated in 54 OT patients (16 men and 38 women; mean age, 69.17 ± 9.64 years; disease duration, 13.83 ± 11.24 years) to probe severity and disability over the immediately preceding one-week period. The 11-item scale showed good internal consistency (Cronbach’s alpha= 0.863) and acceptable (> 0.40) item-to-total correlation [table1]. However, one item was removed at the final Delphi panel due to significant floor effect, poor item-to-total correlation, and poor factor-loading. The test-retest reliability at 2 weeks was excellent (two-way random intraclass correlation coefficient > 0.90), and the individual item test-retest reliability showed good agreement, with a threshold weighted kappa > 0.60 for all items. Exploratory factor analyses revealed a parsimonious two-factor construct accounting for 57.7% of the scale’s variance. A correlation was found between the OT-10 score and the CGI.

Conclusion: The self-administered OT-10 scale is valid and reliable for capturing OT-related severity and disability.

Figure1

Table1

References: 1.Ganos C, Maugest L, Apartis E, et al. The long-term outcome of orthostatic tremor. J. Neurol. Neurosurg. Psychiatry 2016;87(2):167–72. 2.Hellriegel H, Raethjen J, Deuschl G, Volkmann J. Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study. Mov Disord 2011;26(13):2431–4. 3.Dalkey N, Helmer O. An Experimental Application of the DELPHI Method to the Use of Experts. Manage Sci 1963;9(3):458–67. 4.Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 2013;13(1). 5.DeVellis, R. Scale Development: Theory and applications, London, SAGE publications, 2nd edition, 2003, pp 171. 6.Anthoine E, Moret L, Regnault A, Sébille V, Hardouin J-B. Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes 2014;12:176.

To cite this abstract in AMA style:

J. Vizcarra, A. Merola, D. Torres-Russotto, G. Stebbins, A. Wagle Shukla, A. Hassan, L. Marsili, J. Krauss, R. Elble, G. Deuschl, A. Espay. Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10) [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/development-and-validation-of-the-orthostatic-tremor-severity-and-disability-scale-ot-10/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/development-and-validation-of-the-orthostatic-tremor-severity-and-disability-scale-ot-10/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley